Evidence map›Paper›PMID 38264581›Full record

ReviewFrontiers in bioengineering and biotechnology2023

Progress in injectable hydrogels for the treatment of incompressible bleeding: an update.

Xiudan Wang, Xinran Yang, Zhiguang Sun, Xiaoqin Guo, Yanjiao Teng, Shike Hou, Jie Shi, Qi Lv

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiudan WangInstitution of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.
Xinran YangInstitution of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.
Zhiguang SunInstitution of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.
Xiaoqin GuoInstitution of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.
Yanjiao TengInstitution of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.
Shike HouInstitution of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.
Jie ShiInstitution of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.
Qi LvInstitution of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uncontrollable haemorrhage from deep, noncompressible wounds remains a persistent and intractable challenge, accounting for a very high proportion of deaths in both war and disaster situations. Recently, injectable hydrogels have been increasingly studied as potential haemostatic materials, highlighting their enormous potential for the management of noncompressible haemorrhages. In this review, we summarize haemostatic mechanisms, commonly used clinical haemostatic methods, and the research progress on injectable haemostatic hydrogels. We emphasize the current status of injectable hydrogels as haemostatic materials, including their physical and chemical properties, design strategy, haemostatic mechanisms, and application in various types of wounds. We discuss the advantages and disadvantages of injectable hydrogels as haemostatic materials, as well as the opportunities and challenges involved. Finally, we propose cutting-edge research avenues to address these challenges and opportunities, including the combination of injectable hydrogels with advanced materials and innovative strategies to increase their biocompatibility and tune their degradation profile. Surface modifications for promoting cell adhesion and proliferation, as well as the delivery of growth factors or other biologics for optimal wound healing, are also suggested. We believe that this paper will inform researchers about the current status of the use of injectable haemostatic hydrogels for noncompressible haemorrhage and spark new ideas for those striving to propel this field forward.

Indexed as

biomaterialhaemostatic materialhydrogelinjectablenoncompressible haemostasis

Identifiers

PMID38264581
PMCPMC10803650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.